AKT1 and glioblastoma: Elevated expression of PTEN protein and the attenuation of the PI3K-AKT signaling pathway in the tumor tissues was found in the GBM-bearing mouse that received five doses of nanomedicine treatment, which resulted in a remarkable extension of survival.